The Brink's Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Last week saw the newest full-year earnings release from The Brink's Company (NYSE:BCO), an important milestone in the company's journey to build a stronger business. It looks like a pretty bad result, all things considered. Although revenues of US$3.7b were in line with analyst predictions, statutory earnings fell badly short, missing estimates by 57% to hit US$0.55 per share. This is an important time for investors, as they can track a company's performance in its report, look at what top analysts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

View our latest analysis for Brink's

NYSE:BCO Past and Future Earnings, February 10th 2020
NYSE:BCO Past and Future Earnings, February 10th 2020

Taking into account the latest results, the latest consensus from Brink's's five analysts is for revenues of US$3.79b in 2020, which would reflect an okay 2.8% improvement in sales compared to the last 12 months. Statutory earnings per share are expected to jump 615% to US$3.92. Before this earnings report, analysts had been forecasting revenues of US$3.90b and earnings per share (EPS) of US$4.52 in 2020. From this we can that analyst sentiment has definitely become more bearish after the latest results, leading to lower revenue forecasts and a real cut to earnings per share estimates.

Despite the cuts to forecast earnings, there was no real change to the US$108 price target, showing that analysts don't think the changes have a meaningful impact on the stock's intrinsic value. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Brink's at US$116 per share, while the most bearish prices it at US$100.00. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or that analysts have a clear view on its prospects.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. Next year brings more of the same, according to analysts, with revenue forecast to grow 2.8%, in line with its 2.7% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 5.2% per year. So it's pretty clear that Brink's is expected to grow slower than similar companies in the same market.

Advertisement

The Bottom Line

The most important thing to take away is that analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Unfortunately, analysts also downgraded their revenue estimates, and our data indicates revenues are expected to perform worse than the wider market. Even so, earnings per share are more important to the intrinsic value of the business. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that in mind, we wouldn't be too quick to come to a conclusion on Brink's. Long-term earnings power is much more important than next year's profits. We have forecasts for Brink's going out to 2022, and you can see them free on our platform here.

You can also view our analysis of Brink's's balance sheet, and whether we think Brink's is carrying too much debt, for free on our platform here.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

About NYSE:BCO

Brink's

Provides cash and valuables management, digital retail solutions (DRS), and automated teller machines (ATM) managed services in North America, Latin America, Europe, and internationally.

Solid track record, good value and pays a dividend.

Advertisement

Weekly Picks

CE
Ceazar
SPAI logo
Ceazar on Sparc AI ·

When GPS fails: this small cap is fixing a $54B drone problem

Fair Value:CA$5.2537.9% undervalued
150 users have followed this narrative
0 users have commented on this narrative
26 users have liked this narrative
HA
HarishPK
DOX logo
HarishPK on Amdocs ·

Why Amdocs is a high conviction Buy for me?

Fair Value:US$82.0327.9% undervalued
33 users have followed this narrative
3 users have commented on this narrative
11 users have liked this narrative
IV
SBMO logo
Ivoed on SBM Offshore ·

Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

Fair Value:€44.527.2% undervalued
15 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
CL
Clive_Thompson
6831 logo
Clive_Thompson on Green Tea Group ·

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend

Fair Value:HK$8.723.9% undervalued
44 users have followed this narrative
3 users have commented on this narrative
19 users have liked this narrative

Updated Narratives

DZ
VST logo
Dzitkowskik on Vistra ·

Vistra's data centers + AI

Fair Value:US$170.9117.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VA
Valtersa
4013 logo
Valtersa on Dr. Sulaiman Al Habib Medical Services Group ·

Dr. Sulaiman Al Habib Medical worth it or not ?

Fair Value:ر.س26712.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
J_
J_Tyrader
OSCR logo
J_Tyrader on Oscar Health ·

7/8/26 — Oscar Health: Trading 95.4% below Fair Value with +2070.2% Upside Potential

Fair Value:US$583.3495.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28020.0% undervalued
266 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9119.0% overvalued
133 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0942.7% undervalued
162 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative